Clinical trial
Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV…
NCT00441142 · Patrick Y. Wen, MD, Other · Completed
Key facts
| NCT number | NCT00441142 |
|---|---|
| Title | Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain Tumors |
| Official title | Phase I/II Study of ZD6474 (Vandetanib) With Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Newly-Diagnosed Glioblastoma |
| Acronym | Zactima |
| Lead sponsor | Patrick Y. Wen, MD, Other |
| Collaborators | Dana-Farber Cancer Institute Beth Israel Deaconess Medical Center Massachusetts General Hospital University of Virginia Memorial Sloan Kettering Cancer Center Henry Ford Hospital |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma Multiforme, Gliosarcoma |
| Intervention type | Drug, Radiation |
| Interventions | ZD6474, temozolomide, Radiation Therapy |
| Enrollment | 119 |
| Start date | May 25, 2007 |
| Primary completion | Aug 31, 2013 |
| Completion | Oct 10, 2017 |
| First posted | Feb 28, 2007 |
| Last update posted | Mar 5, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: